BioPharma Resources

Drug Trial Radar · NCT07422285

Comparing the Extent to Which Two Evolocumab Drug Products Are Made Available in the Body After a Single Subcutaneous Dose

An Open-label, Phase 1, Single Dose, Randomized, Parallel-group Study to Evaluate the Relative Bioavailability of Two Evolocumab (AMG 145) Drug Products

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 405 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

405

Actual

Start

Jan 16, 2026

Primary completion

Jul 24, 2026

Study completion Jul 31, 2026

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Feb 20, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The main objective of this trial is to evaluate the pharmacokinetics of two evolocumab drug products in healthy participants.

Conditions

  • Healthy Participants
  • Pharmacokinetics

Interventions

  • Evolocumab Drug Substance ADrug

    Evolocumab drug substance A will be administered SC.

  • Evolocumab Drug Substance BDrug

    Evolocumab drug substance B will be administered SC.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area Under the Concentration-time Curve (AUC) from Time 0 Extrapolated to Infinity (AUCinf) of EvolocumabTime frame: Day 1 to Day 64
  2. Area Under the Concentration-time Curve from Time 0 to Time of Last Quantifiable Concentration (AUClast) of EvolocumabTime frame: Day 1 to Day 64
  3. Maximum Observed Concentration (Cmax) of EvolocumabTime frame: Day 1 to Day 64

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • QPS Bio-Kinetic

    Springfield, Missouri

  • Ohio Clinical Trials, Inc.

    Columbus, Ohio

  • Fortrea Clinical Research Unit - Dallas

    Dallas, Texas

  • Fortrea Clinical Research Unit Inc. - Madison

    Madison, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.